Clinical trial NCT02501174: Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).
Official title: Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cancer
Keywords: Geriatric oncology
Lead sponsor: Centre Oscar Lambret
Sponsor class: OTHER
First posted: 2015-07-17
Enrollment: 2914
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients included are patients followed in one of the participating centres and not opposing the use of their medical data.

Brief summary: The aim of this study is to establish a common geriatric oncology medical database. The patients concerned are the patients having benefited from a geriatric oncology consultation in one of the participating centres. This database is designed with a view on the one hand to better describe to better understand this population and on the other hand to facilitate the conduct of future retrospective or prospective studies on this population. The constitution of this observatory of patients seen in consultation should facilitate the development of studies from the analysis of data collected, and occasional surveys by the rapid identification of cases. Data from this database could provide clinicians with valuable informative elements of descriptive epidemiology and concerning the organization of care in the geriatric oncology field.

Detailed description: The study is presented during the first consultation of oncogeriatric care or after this consultation (for patients having benefited from the consultation between January 2014 and October 2014) : the patient is informed with an information note and is told that he can express its opposition to the use of its clinical data. In case of no opposition from the patient, the referent geriatrician will complete the patient form with the requested data and will forward it for computerized processing.

Eligibility criteria: Inclusion Criteria:

* Patient seen in consultation of geriatric oncology in one of the participating centres in Nord Pas-de-Calais.
* Age ≥ 65 years
* Patient having been informed and not opposing the computerized processing of its data.

Exclusion Criteria:

* Patient having opposed the use of its medical data.

Primary outcomes:
measure: Measurement of the prevalence of different clinical criteria of interest : demographic characteristics, disease state, patient status according to the geriatric criteria (Comprehensive Geriatric Assessment (CGA)).
timeFrame: Up to 5 years
Secondary outcomes:
measure: Measurement of the prevalence of different medical and social criteria of interest.
timeFrame: Up to 5 years
measure: Measurement of the association between one or more factors of interest (clinical, biological and medical and social) related to a proposal to amend or not the initially proposed therapeutic strategy.
timeFrame: Up to 5 years
measure: Percentage of patients included in trials.
timeFrame: Up to 5 years
measure: Temporal evolutions of clinical, medical and social characteristics.
timeFrame: Up to 5 years
Other outcomes:
Locations:
city: Arras
country: France
facility: Centre Hospitalier d'Arras
city: Boulogne sur Mer
country: France
facility: Centre Hospitalier
city: Béthune
country: France
facility: Centre Hospitalier
city: Douai
country: France
facility: Centre Hospitalier, Douai
city: Dunkerque
country: France
facility: Centre Hospitalier
city: Le Cateau-Cambrésis
country: France
facility: Hospitalier Le Cateau-Cambresis
city: Lille
country: France
facility: CHRU de Lille
city: Lille
country: France
facility: Hôpital Saint Vincent de Paul
city: Lille
country: France
facility: Centre Oscar Lambret
city: Liévin
country: France
facility: Polyclinique de Riaumont
city: Lomme
country: France
facility: Hôpital Saint-Philibert
city: Roubaix
country: France
facility: Clinique Saint Jean, Roubaix
city: Tourcoing
country: France
facility: Centre Hospitalier
city: Valenciennes
country: France
facility: Centre de cancérologie Les Dentellières
city: Valenciennes
country: France
facility: Centre Hospitalier
Study officials:
affiliation: CHRU de Lille
name: Cédric GAXATTE, MD
role: PRINCIPAL_INVESTIGATOR
References: